PagerDuty, Inc. , a global leader in digital operations management, announced today the appointment of David Williams as Senior Vice President of Product. Williams will lead all products and core ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), a Fort Lauderdale-based ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

At closing of the transaction, JASMIN shall acquire Pierre Fabre's R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders ...

Cohen encouraged researchers to look at biomarker patterns within racial minority groups with dementia, rather than only ...

REDWOOD CITY, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development ...

23. Dahiya D, Mackin C, Nigam PS. Studies on bioactivities of Manuka and regional varieties of honey for their potential use ...

An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.

Finnish researchers show in a new study that pituitary macrophages, the immune cells located in the pituitary gland, help ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

Enlivex is a clinical stage macrophage reprogramming immunotherapy company developing Allocetra™, a universal, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state ...

Each UC campus now resides among the exclusive group of 187 accredited doctoral-granting universities in the United States ...